2014
DOI: 10.1186/1471-2334-14-488
|View full text |Cite
|
Sign up to set email alerts
|

Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment

Abstract: BackgroundMucormycosis is an invasive mycotic disease caused by fungi in the zygomycetes class. Although ubiquitous in the environment, zygomycetes are rarely known to cause invasive disease in immunocompromised hosts with a high mortality even under aggressive antifungal and surgical therapy. Clinically, mucormycosis frequently affects the sinus occasionally showing pulmonary or cerebral involvement. However skeletal manifestation with Rhizopus microsporus (RM) osteomyelitis leading to emergency surgical prox… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 22 publications
(41 reference statements)
0
7
0
Order By: Relevance
“…Osteoarticular mucormycosis is a highly destructive infection with poor prognosis, if not diagnosed early. 151 …”
Section: Discussionmentioning
confidence: 99%
“…Osteoarticular mucormycosis is a highly destructive infection with poor prognosis, if not diagnosed early. 151 …”
Section: Discussionmentioning
confidence: 99%
“…Similarly, a study in neutropenic mice infected with R. oryzae found that amphotericin B and posaconazole dose combination did not prolong survival or decrease organ fungal burden to a greater extent than AMB monotherapy [ 79 ]. Human studies evaluating polyene-triazole combination for the treatment of mucormycosis are limited [ 76 , 80 , 81 , 82 , 83 , 84 , 85 ]. In one retrospective case series, 32 patients with hematological malignancies or aplastic anemia, and mucormycosis unresponsive to prior monotherapy (mainly with LAMB), were treated with combination of polyene and posaconazole [ 86 ].…”
Section: Treatmentmentioning
confidence: 99%
“…Mucormycosis is an emerging angioinvasive infection caused by ubiquitous filamentous fungi of the order Mucorales that commonly affect the sinuses (39%) and the lungs (24%) [5,6]. To establish infection, Mucorales species form spores that are small (3-11 µm) enough to reach the distal alveolar spaces and then overcome phagocytosis by macrophages and neutrophils to germinate into hyphae [3].…”
Section: Discussionmentioning
confidence: 99%